The trial for a new vaccine against dengue fever has recently concluded with less than optimal results. The vaccine was able to prevent dengue fever in 56% of the test population, and it was able to protect 88% from severe disease. While the desired protection rate would be to have immunity over 90%, this vaccine is still more than what was available in the past. This mosquito born illness is not expected to reach the U.S. mainland, but it is already endemic in Puerto Rico, the U.S. Virgin Islands, and the U.S. territories in the Pacific Ocean. How do you educate your patients on the importance of vaccination?
Find more information at WebMD
Image courtesy of [arztsamui]/FreeDigitalPhotos.Net